HeartFlow Inc (HTFL) Company Revenue

Symbol and logo of brand HeartFlow (HTFL)

Heartflow Inc (HTFL) sales volume history demonstrates the effectiveness of cloud AI that creates 3D blood flow models to replace invasive procedures, with the current value standing at 0.21. Revolutionary ischemia diagnostic platforms are driving rapid commercial growth and reducing mortality rates. The application of computer modeling supports ESG compliance by reducing the consumption of medical reagents and plastics.

HTFL heartflow.com: Company Sales in the range 08/09/2025 - 11/13/2026

Comprehensive metric breakdowns and analytics for HeartFlow, Inc. (HTFL)

- stock price and consensus target price:
Quote Chart heartflow.com|HTFL - Price Target Chart
- market capitalization details:
Market Value HeartFlow, Inc.|HTFL - Total Company Value
- book capitalization information:
Net Asset Value per Share HeartFlow|HTFL - Company Net Assets|Market Cap to Net Assets Ratio heartflow.com|HTFL - Cumulative Company Assets
- company liabilities and liquidity data:
All Debt to Shareholders' Equity Ratio Heartflow Inc|HTFL - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient HeartFlow Inc|HTFL - Company Debts|Debt to Book Value Ratio HeartFlow, Inc.|HTFL - Company Long-Term Debts|Company Current Liabilities HeartFlow|Intermediate Coverage Ratio heartflow.com
- business earnings and investment ratios data:
HTFL - Net Income|Future Net Profit Heartflow Inc|HTFL - P/E Multiple|Price to Expected Earnings Ratio Heartflow Inc|HTFL - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HeartFlow, Inc.|HTFL - Operating profit EBITDA|Earnings per share for the trailing year HeartFlow|HTFL - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months heartflow.com|HTFL - Earnings growth in current year|Earnings growth forecast for next year Heartflow Inc
- issuer revenue and sales details:
HTFL - Company Revenue|Company Future Revenue HeartFlow, Inc.|HTFL - Market Cap to Revenue|Price to Expected Revenue Ratio HeartFlow, Inc.
Comprehensive company analysis:HeartFlow Medical HTFL
Flagship merchandise of HeartFlow Inc

A comparative analysis of this asset requires benchmarking revenue dynamics against the US industry cycle, where extremes are indexed through the lens of market liquidity. This metric captures daily cash inflows from product sales, which for Heartflow Inc (HTFL) signifies the scaling of cloud licenses with high operating leverage; consequently, the company's growth in sales volume directly confirms the effectiveness of the commercial implementation of AI diagnostics.

Key competitors

Regeneron Corp - Company Annual Revenue|Company Revenue iRhythm Technologies (IRTC)|Company Revenue LNTH (lantheus.com)|Company Revenue Mineralys Therapeutics, Inc. MLYS|Kestra Medical Technologies, Inc. (KMTS) - Company Total Revenue|ESPR: Company Sales|Amarin Pharma (AMRN) - Company Sales|AVR (anteristech.com) - Company Sales|Tenaya Therapeutics, Inc. - Company Sales Revenue|CVRX (CVRx) - Revenue and Sales Volume|Milestone Pharmaceuticals, Inc. (MIST) - Company Gross Revenue|Company Revenue Cardiol Therapeutics (CRDL)|HeartBeam Corporation - Company Sales Volume|Revenue and Sales Volume TENX (Tenax Therapeutics)|ADGM - Company Sales|BioCardia - Revenue and Sales Volume|Company Sales Revenue VTAK (Catheter Precision Inc)|ABIO (arcabio.com) - Company Sales|ACST: Company Total Sales|AVTE (Aerovate Therapeutics) - Revenue and Sales Volume|Verve - Company Annual Revenue|Company Revenue Windtree Therapeutics (WINT)